KIRKLAND, QC, Nov. 24, 2015 /CNW Telbec/ – Ortho Regenerative Technologies Inc. (“Ortho RTi”), a Canadian orthopaedic biotechnology company, announced today that it has filed a preliminary prospectus with the securities regulatory authorities of all provinces and territories in Canada. The non-financing prospectus was

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone